Professional
Added to YB: 2024-09-11
Pitch date: 2024-06-30
TMDX [bullish]
TransMedics Group, Inc.
-11.95%
current return
Author Info
No bio for this author
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$4.6B
Pitch Price
$150.91
Price Target
N/A
Dividend
N/A
EV/EBITDA
36.30
P/E
52.77
EV/Sales
8.17
Sector
Health Care Equipment and Supplies
Category
growth
Meridian Growth Fund Portfolio Holding: TransMedics Group, Inc.
TMDX trimmed position: OCS tech enables more efficient organ transplants, expanding market & taking share. Strong Q growth, increased adoption, profitability ahead of plan. Revolutionary tech & proprietary logistics network drive future growth. Position trimmed on valuation after share price appreciation.
Read full article (1 min)